Original document(7 pages)  中文版
    The present invention relates to a carvedilol oral disintegrant preparation. It contains 5-20% of carvedilol, and the rest is auxiliary material, including mannitol, lactose, avicel, low-substituted hydroxypropyl cellulose, cross-linked carboxymethylcellulose sodium, citric acid, micropowder silica gel, magnesium stearate and essence, etc. Said invention adopts powder direct tabletting process to make preparation.
Application Number
申请号		 200610096694 Application Date
申请日		 2006.10.18
Title 名称 Carvedilo oral disintegrating tablet
Publication Number
公开号		 1935123 Publication Date
公开日		 2007.03.28
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/20;A61K31/405;A61P9/12;A61P9/04
Applicant(s) Name
申请人		 Geng Yan
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 wuqi yun
More information 更  多  信  息


 Related patents information
Daidzein drip pill and its preparation method
Ambroxol hydrochloride drop pills and its preparation method
Camptothecine derivative and its preparation
Camptothecine derivatives and their use
Fluorescent quantitative RT-PCR detecting kit of 2-f(o)etoprotein (AFP)mRNA
Camptothecin derivative used as anti-tumor agent and preparation method thereof
Orally disintegrated galantamine hydrobromide tablet and its prepn process
Carvedilol dripping pill and its prepn process
Novel anti-tumor compound and its preparing method
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.